Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06963684 · ClinicalTrials.gov registry record · NA

Glaucoma Laser Assessment of Stability and Sustainability

A NA study of Glaucoma, sponsored by Twin Cities Eye Consultants.

Recruiting
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT06963684 is a NA study of Glaucoma that is actively recruiting participants, run by Twin Cities Eye Consultants. The registered enrollment target is 48 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06963684, a NA study of Glaucoma, is actively recruiting participants, sponsored by Twin Cities Eye Consultants.

RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The GLASS Study is designed to help researchers learn whether repeating a non-invasive laser treatment called DSLT (Direct Selective Laser Trabeculoplasty) can better control eye pressure in patients with early-stage glaucoma or ocular hypertension. All participants will receive the laser treatment in both eyes. After three months, one eye will be randomly selected to receive a second treatment, while the other eye will serve as a comparison. The goal is to see whether two treatments work better than one at keeping eye pressure low without using daily eye drops. This study will help doctors decide the best way to use this laser treatment to manage glaucoma and delay the need for medication. Participants will be followed for one year to monitor safety, eye pressure, and the need for any additional treatments.

Conditions Studied

Glaucoma

Interventions

  • DEVICE Dual-Treatment Direct Selective Laser Trabeculoplasty (DSLT)

Study Locations (1)

Minnesota

  • Twin Cities Eye Consultants - Coon Rapids

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2025-06
Est. Completion 2027-08
Phase NA

Sponsor

Twin Cities Eye Consultants

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06963684

The ClinicalTrials.gov registry entry for NCT06963684 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (95% lower). The listed sponsor is Twin Cities Eye Consultants, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which Dual-Treatment Direct Selective Laser Trabeculoplasty (DSLT) is the first listed.

NCT06963684 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06963684 about?

NCT06963684 is a clinical study titled "Glaucoma Laser Assessment of Stability and Sustainability". The GLASS Study is designed to help researchers learn whether repeating a non-invasive laser treatment called DSLT (Direct Selective Laser Trabeculoplasty) can better control eye pressure in patients with early-stage glaucoma or ocular hypertension. All participants will receive the laser treatment ...

What is the current status of trial NCT06963684?

This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2025-06. Estimated completion is 2027-08.

What conditions does trial NCT06963684 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT06963684?

The interventions under investigation include: Dual-Treatment Direct Selective Laser Trabeculoplasty (DSLT) (DEVICE).

Who is sponsoring clinical trial NCT06963684?

This trial is sponsored by Twin Cities Eye Consultants, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06963684 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Glaucoma

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.